SLG
SCLN

Stanley-Laman Group’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Stanley-Laman Group’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-87,882
Closed -$443K – 358
2013
Q4 		$443K Buy
+87,882
New +$443K 0.1% 145